· Original article
GSK Cancer Trials Could Nearly Double in 2027
GSK cancer trials could expand substantially in 2027 as the drugmaker rebuilds its oncology portfolio ahead of expiring HIV drug patents.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 4,001 · Page 133 / 334
· Original article
GSK cancer trials could expand substantially in 2027 as the drugmaker rebuilds its oncology portfolio ahead of expiring HIV drug patents.
· Original article
Novartis stock rose 3.1% on October 27, 2026, after the company raised its full-year core operating income outlook as European shares declined.
· Original article
The TotalEnergies stake sale transfers a 10% interest in Nigeria’s Renaissance joint venture to Vaaris while retaining rights to three gas licenses.
· Original article
Hycroft Mining reported $211 million in unrestricted cash and no debt as it advanced drilling and processing studies at its Nevada mine.
· Original article
Indore Comic Con will bring NODWIN Gaming’s pop-culture festival to Madhya Pradesh for the first time on December 19–20, 2026.
· Original article
India semiconductor supply chains need manufacturing capacity and industry-ready talent, stakeholders said at Semiconductor Summit 2026.
· Original article
Radico Khaitan earnings rose in the September quarter as premium spirits volumes grew, prompting the company to raise its FY27 volume guidance.
· Original article
Small cap funds led by Bandhan recorded three-year annualized returns of 15.4% to 20.1% as of October 21, 2026.
· Original article
Big Tech earnings from Amazon, Microsoft and Alphabet will test expectations for cloud growth as investors scrutinize the cost of AI infrastructure.
· Original article
Porsche earnings rebounded in the first nine months of 2026 despite lower revenue and deliveries, as the carmaker reduced its exposure to China.
· Original article
Anthropic cash reserves could approach $400 billion by the end of 2027, based on an estimate that includes anticipated IPO proceeds and pledges.
· Original article
Iovance earnings for the third quarter of 2026 are scheduled for discussion on November 5, alongside corporate updates.
Charts and market data by TradingView. Availability and delays vary by exchange.